Since BDNF expression is decreased in the hippocampal and temporal lobes of patients with AD or AD model rats, measuring BDNF, TrkB, and CREB expression levels may be useful for assessing AD progression [23,24]. The gene discussed is CREB1; the disease is Alzheimer disease.